Diagnostic and prognostic role of procalcitonin in infections

TheScientificWorldJournal

Volumn 10, Issue , 2010, Pages 1941-1946

  Hatzistilianou, Maria ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Bacterial infection; Cytokines; Hematological malignancies; Immunocompromised patients; Neutropenia; Pneumonia; Procalcitonin

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; PROCALCITONIN; BIOLOGICAL MARKER; CALCITONIN; PROTEIN PRECURSOR;

ANTIBIOTIC THERAPY; BACTERIAL INFECTION; BACTERIAL PNEUMONIA; CHILDHOOD DISEASE; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEBRILE NEUTROPENIA; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; INFECTION; INFECTIOUS PNEUMONIA; PNEUMONIA; PROCALCITONIN BLOOD LEVEL; PROGNOSIS; PROTEIN BLOOD LEVEL; REVIEW; SENSITIVITY AND SPECIFICITY; VIRUS PNEUMONIA; BLOOD; METHODOLOGY; MONITORING; REPRODUCIBILITY; SEPSIS;

BACTERIA (MICROORGANISMS);

BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; CALCITONIN; HUMANS; MONITORING, PHYSIOLOGIC; PROGNOSIS; PROTEIN PRECURSORS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEPSIS;

EID: 78349248599     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2010.181     Document Type: Review

References (42)

1. Le Moullec, J.M., Jullienne, A., Chenais, J., Lasmoles, F., Guliana, J.M., Milhaud, G., and Moukhtar, M.S. (1984) The complete sequence of human procalcitonin. FEBS Lett. 167, 93-97.
2. Assicot, M., Gendrel, D., Carsin, H., Raymond, J., Guilbaud, J., and Bohuon, C. (1993) High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341, 515-518.
3. Chesney, R.W., McCarron, D.M., Haddad, J.G., Hawker, C.D., DiBella, F.P., Chesney, P., and Davis, J.P.(1983) Pathogenic mechanism of the hypocalcemia of the staphylococcal toxic-shock syndrome. J. Lab. Clin. Med. 101, 576-585.
4. Becker, K., Müller, B., Nylen, E., Cohen, R., Silva, O., and Snider, R. (2001) Calcitonin gene family of peptides. In Principles and Practice of Endocrinology and Metabolism. Becker, K., Ed. Lippincott, Philadelphia. pp. 520-534.
5. Becker, K.L., Nylén, E.S., White, J.C., Müller, B., and Snider, R.H., Jr. (2004) Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J. Clin. Endocrinol. Metab. 89, 1512-1525.
6. Muller, B., White, J.C., Nylen, E., Snider, R.H., Becker, K.L., and Habener, J.F. (2001) Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J. Clin. Endocrinol. Metab. 86, 396-404.
7. Whicher, J., Bienvenu, J., and Monneret, G. (2001) Procalcitonin as an acute phase marker. Ann. Clin. Biochem. 38, 483-493.
8. Chastre, J., Luyt, C.E., Trouillet, J.L., and Combes, A. (2006) New diagnostic and prognostic markers of ventilatorassociated pneumonia. Curr. Opin. Crit. Care, 12, 446-451.
9. Nijsten, M.W., Olinga, P., The, T.H., et al. (2000) Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit. Care Med. 28, 458-461. (Pubitemid 30120889)
10. Oberhoffer, M., Stonans, I., Russwurm, S., et al. (1999) Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro. J. Lab. Clin. Med. 134, 49-55.
11. Sachse, C., Dressler, F., and Henkel, E. (1998) Increased serum procalcitonin in newborn infants without infection. Clin. Chem. 44, 1343-1344.
12. Lapillonne, A., Basson, E., Monneret, G., Bienvenu, J., and Salle, B.L. (1998) Lack of specificity of procalcitonin for sepsis diagnosis in premature infants. Lancet, 351, 1211-1212. (Pubitemid 28171843)
13. Simon, L., Saint-Louis, P., Amre, D.K., Lacroix, J., and Gauvin, F. (2008) Procalcitonin and C-reactive protein as markers of bacterial infection in critically ill children at onset of systemic inflammatory response syndrome. Pediatr. Crit. Care Med. 9, 407-413.
14. Schneider, H.G. and Lam, Q.T. (2007) Procalcitonin for the clinical laboratory: a review. Pathology 39, 383-390.
15. Becker, K.L., Snider, R., and Nylen, E.S. (2008) Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit. Care Med. 36, 941-952.
16. Christ-Crain, M. and Muller, B. (2007) Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators. Eur. Respir. J. 30, 556-573. (Pubitemid 351182082)
17. de Kruif, M.D., Limper, M., Gerritsen, H., Spek, C.A., Brandjes, D.P., et al. (2010) Additional value of procalcitonin for diagnosis of infection in patients with fever at the emergency department. Crit. Care Med. 38, 457-463.
18. Christ-Crain, M. and Muller, B. (2005) Procalcitonin in bacterial infections: hype, hope, more or less? Swiss Med. Wkly. 135, 451-460.
19. Don, M., Valent, F., Korppi, M., Falleti, E., De Candia, A., Fasoli, L., Tenore, A., and Canciani, M. (2007) Efficacy of serum procalcitonin in evaluating severity of community-acquired pneumonia in childhood. Scand. J. Infect. Dis. 39, 129-137.
20. Andreola, B., Bressan, S., Callegaro, S., et al. (2007) Procalcitonin and C-reactive protein as diagnostic markers of severe bacterial infections in febrile infants and children in the emergency department. Pediatr. Infect. Dis. J. 26, 672-677.
21. Bressan, S., Andreola, B., Cattelan, F., et al. (2010) Predicting severe bacterial infections in well-appearing febrile neonates laboratory markers accuracy and duration of fever. Pediatr. Infect. Dis. J. 29, 227-232.
22. Trautner, B.W., Caviness, A.C., Gerlacher, G.R., et al. (2006) Prospective evaluation of the risk of serious bacterial infection in children who present to the emergency department with hyperpyrexia (temperature of 106 degrees F or higher). Pediatrics 118, 34-40.
23. Pulliam, P.N., Attia, M.W., and Cronan, K.M. (2001) C-reactive protein in febrile children 1 to 36 months of age with clinically undetectable serious bacterial infection. Pediatrics 108, 1275-1279.
24. Olaciregui, I., Hernandez, U., Munoz, J.A., Emparanza, J.I., and Landa, J.J. (2009) Markers that predict serious bacterial infection in infants under 3 months of age presenting with fever of unknown origin. Arch. Dis. Child. 94, 501-505.
25. Hatzistilianou, M., Hitoglou, S., Gougoustamou, D., Rekliti, A., Tzouvelekis, G., Nanas, Ch., Catriu, D., and Kotsis, A. (2002) Serum procalcitonin, adenosine deaminase and its isoenzymes in the aetiological diagnosis of pneumonia in children. Int. J. Immunopathol. Pharmacol. 15, 119-127. (Pubitemid 34712440)
26. Christ-Crain, M., Stolz, D., Bingisser, R., et al. (2006) Procalcitonin guidance of antibiotic therapy in communityacquired pneumonia: a randomized trial. Am. J. Respir. Crit. Care Med. 174, 84-93. (Pubitemid 43955248)
27. Briel, M., Schuetz, P., Mueller, B., et al. (2008) Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Arch. Intern. Med. 168, 2000-2007, discussion 2007-2008.
28. Ball, P., Baquero, F., Cars, O., et al. (2002) Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence. J. Antimicrob. Chemother.. 49, 31-40.
29. Huang, D.T., Weissfeld, L.A., Kellum, J.A., Yealy, D.M., Kong, L., Martino, M., Angus, D.C.; GenIMS Investigators (2008) Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia. Ann. Emerg. Med. 52, 48-58.
30. Hitoglou-Hatzi, S., Hatzistilianou, M., Gougoustamou, D., Rekliti, A., Agguridaki, C., Athanassiadou, F., Frydas, S., Kotsis, A., and Catriu, D. (2005) Serum adenosine deaminase and procalcitonin concentrations in neutropenic febrile children with acute lymphoblastic leukaemia. Clin. Exp. Med. 5, 60-65.
31. Hatzistilianou, M. (2008) The role of procalcitonin in febrile neutropenic children with haematological malignancies. US Pediatr. 10, 77-79.
32. Hatzistilianou, M., Rekliti, A., Athanassiadou, F., and Catriu, D. (2010) Procalcitonin as an early marker of bacterial infection in neutropenic febrile children with acute lymphoblastic leukemia. Inflamm. Res. 59, 339-347.
33. Hatzistilianou, M., Rekliti, A., Athanassiadou, F., et al. (2007) Serial procalcitonin responses in infection of children with secondary immunodeficiency. Clin. Invest. Med. 30, 75-85.
34. Hatzistilianou, M., Reklity, A., Athanassiadou, F., Aggouridaki, Ch., and Catriu, D. (2002) Procalcitonin and Inflammatory Cytokine mRNA in Children with Secondary Immunodeficiency. Proccedings of the 10th Meeting of the European Society for Immunodeficiences.
35. Massaro, K., Costa, S., Leone, C., and Chamone, D. (2007) Procalcitonin (PCT) and C-reactive Protein (CRP) as severe systemic infection markers in febrile neutropenic adults. BMC Infect. Dis. 7, 137-142.
36. Secmeer, G., Devrim, I., Kara, A., Ceyhan, M., Cengiz, B., Kutluk, T., Buyukpamukcu, M., Yetgin, S., Tuncer, M., Uludag, A.K., Tezer, H., and Yildirim, I. (2007) Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia. J. Pediatr. Hematol. Oncol. 29, 107-111.
37. Zivanovic, S., Saranac, L., Kostic, G., Bogicevic, V., and Jovancic, D. (2010) A case of acute tuberculous pleuropneumonia in a patient with acute lymphoblastic leukemia. TheScientificWorldJOURNAL 10, 578-585.
38. Athanassiadou, F., Hatzistilianou, M., Rekliti, A., and Catriu, D. (2003) Comparative study of two methods for the determination of procalcitonin. Ped. North. Gr. 15, 40-45. [Greek]
39. Galetto-Lacour, A., Zamora, S.A., and Gervaix, A. (2003) Bedside procalcitonin and C-reactive protein tests in children with fever without localizing signs of infection seen in a referral center. Pediatrics 112, 1054-1060.
40. Tseng, J.S., Chan, M.C., Hsu, J.Y., Kuo, B.I.T., and Wu C.L. (2008) Procalcitonin is a valuable prognostic marker in ARDS caused by community-acquired pneumonia. Respirology 13, 505-509.
41. Franzin, L. and Cabodi, D. (2005) Legionella pneumonia and serum procalcitonin. Curr. Microbiol. 50, 43-46.
42. Haeuptle, J., Zaborsky, R., Fiumefreddo, R., et al. (2009) Prognostic value of procalcitonin in Legionella pneumonia. Eur. J. Clin. Microbiol. Infect. Dis. 28, 55-60.